Optogenetic reporters delivered as mRNA facilitate repeatable action potential and calcium handling assessment in human iPSC-derived cardiomyocytes

• Published in: Stem cells (Dayton, Ohio) Ohio), 2022-07, Vol.40 (7), p.655-668
• Main Authors: Yiangou, Loukia, Blanch-Asensio, Albert, de Korte, Tessa, Miller, Duncan C, van Meer, Berend J, Mol, Mervyn P H, van den Brink, Lettine, Brandão, Karina O, Mummery, Christine L, Davis, Richard P
• Format: Article
• Language: English
• Subjects: Embryonic Stem Cells/Induced Pluripotent Stem Cells
• ISSN: 1066-5099; 1549-4918
• DOI: 10.1093/stmcls/sxac029

Electrical activity and intracellular Ca 2+ transients are key features of cardiomyocytes. They can be measured using organic voltage- and Ca 2+-sensitive dyes but their photostability and phototoxicity means they are unsuitable for long-term measurements. Here, we investigated whether genetically-encoded voltage and Ca 2+ indicators (GEVIs and GECIs) delivered as modified mRNA (modRNA) into human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) would be accurate alternatives allowing measurements over long periods. These indicators were detected in hiPSC-CMs for up to 7 days after transfection and did not affect responses to proarrhythmic compounds. Furthermore, using the GEVI ASAP2f we observed action potential prolongation in long QT syndrome models, while the GECI jRCaMP1b facilitated the repeated evaluation of Ca 2+ handling responses for various tyrosine kinase inhibitors. This study demonstrated that modRNAs encoding optogenetic constructs report cardiac physiology in hiPSC-CMs without toxicity or the need for stable integration, illustrating their value as alternatives to organic dyes or other gene delivery methods for expressing transgenes.